The 2021 Pfizer’s Centers for Therapeutic Innovation (CTI) Call for Proposals is seeking partnering opportunities for novel targets in the areas described below with applications across Pfizer’s core therapeutic areas.
Submission Deadline: June 28th 2021
Areas of interest:
- Develop a 2-3 page non-confidential document outlining the scientific background and research synopsis
- Pre-proposals should be reviewed by one of Pfizer’s Emerging Science Leads to determine suitability prior to
submission, formal submission should be routed through business/tech-transfer offices.
For more information about the areas of interest, the CTI’s collaboration model and submission procedure go to https://www.pfizercti.com or email email@example.com. Also, more info via the following PDF.
What is Pfizer’s Centers for Therapeutic Innovation?
Established in 2010, Pfizer’s Centers for Therapeutic Innovation (CTI) was founded on the notion that our current scientific and global health challenges are too complex for any one player in the healthcare ecosystem to solve alone. We believe that collaboration is critical to success. CTI collaborates with academic institutions and investigators to push forward great science, using the depth and breadth of the Pfizer enterprise to accelerate concepts into viable therapies with breakthrough potential for patients.